Table 1.
50% Neutralization Sensitivity of Infant Envelope Clones
| Infant MHP ID | 1B12 μg/ml | 2G12 μg/ml | 2F5 μg/ml | 4E1O μg/ml | sCD4 μg/ml | PG-9 μg/ml | PG-16 μg/ml | VRC01 μg/ml | CH31 μg/ml | HIVIG-C dilution |
|---|---|---|---|---|---|---|---|---|---|---|
| 329 | >25 | >25 | >25 | 17.11 | 13.54 | <0.01 | <0.01 | <0.01 | 7.62 | 11.23 |
| 591 | 8.88 | >25 | >25 | 5.78 | 15.11 | 0.17 | 0.03 | 0.08 | 0.16 | 71.69 |
| 703 | >25 | >25 | >25 | 7.52 | 7.14 | 0.43 | 0.03 | 0.15 | 0.06 | 59.35 |
| 942 | >25 | >25 | >25 | 0.75 | 21.15 | 0.06 | 0.03 | >25 | >25 | 65.05 |
| 1266 | >25 | >25 | >25 | 13.36 | >25 | 0.02 | <0.01 | 0.05 | 0.13 | 93.65 |
| 1677 | >25 | >25 | >25 | >25 | >25 | 1.06 | >25 | 1.5 | 0.43 | 103.89 |
MHP, malaria and HIV-1 in pregnancy.